Related references
Note: Only part of the references are listed.Contribution of Rare Genetic Variation to Disease Susceptibility in a Large Scandinavian Myositis Cohort
Matteo Bianchi et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study
Isak Samuelsson et al.
LUPUS SCIENCE & MEDICINE (2021)
C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205
Helena Enocsson et al.
FRONTIERS IN IMMUNOLOGY (2021)
Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
Benoit Brilland et al.
FRONTIERS IN IMMUNOLOGY (2021)
CRP Enhances the Innate Killing Mechanisms Phagocytosis and ROS Formation in a Conformation and Complement-Dependent Manner
Johannes Zeller et al.
FRONTIERS IN IMMUNOLOGY (2021)
Plasma C-Reactive Protein and Pentraxin-3 Reference Intervals During Normal Pregnancy
Lina Wirestam et al.
FRONTIERS IN IMMUNOLOGY (2021)
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical associations of renal involvement in ANCA-associated vasculitis
Andreas Kronbichler et al.
AUTOIMMUNITY REVIEWS (2020)
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus
Helena Enocsson et al.
JOURNAL OF AUTOIMMUNITY (2020)
The antiphospholipid syndrome - often overlooked cause of vascular occlusions?
E. Svenungsson et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization
Eva Karpati et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings
Mariele Gatto et al.
JOURNAL OF AUTOIMMUNITY (2020)
The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression
Zeyu Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein
Hai-Yun Li et al.
CARDIOVASCULAR RESEARCH (2019)
Shared and Unique Patterns of DNA Methylation in Systemic Lupus Erythematosus and Primary Sjogren's Syndrome
Juliana Imgenberg-Kreuz et al.
FRONTIERS IN IMMUNOLOGY (2019)
Systemic lupus erythematosus is associated with poor outcome after acute myocardial infarction
Shin-Rong Ke et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2019)
IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review
Atsushi Ogata et al.
MODERN RHEUMATOLOGY (2019)
Human periodontal ligament fibroblasts synthesize C-reactive protein and Th-related cytokines in response to interleukin (IL)-6 trans-signalling
A. Hernandez-Caldera et al.
INTERNATIONAL ENDODONTIC JOURNAL (2018)
Oxidation of C-reactive protein by hypochlorous acid leads to the formation of potent platelet activator
Magdalena Boncler et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Pentraxins and Fc Receptor-Mediated Immune Responses
Jinghua Lu et al.
FRONTIERS IN IMMUNOLOGY (2018)
It's time to redefine inflammation
Maria Antonelli et al.
FASEB JOURNAL (2017)
Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus
Marios Rossides et al.
JOURNAL OF RHEUMATOLOGY (2017)
Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis
Qiu-yu Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Genetic variants in FH are associated with renal histopathologic subtypes of lupus nephritis: a large cohort study from China
M. Tan et al.
LUPUS (2017)
The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study
Marie-Louise Hermansen et al.
RHEUMATOLOGY (2017)
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study
J. Antonio Avina-Zubieta et al.
ARTHRITIS CARE & RESEARCH (2017)
Stroke in systemic lupus erythematosus: a Swedish population-based cohort study
Elizabeth V. Arkema et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials
Amirhossein Sahebkar et al.
AUTOIMMUNITY REVIEWS (2016)
Collectin CL-P1 utilizes C-reactive protein for complement activation
Nitai Roy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Cause and consequences of the activated type I interferon system in SLE
Maija-Leena Eloranta et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
The dysfunctions of complement factor H in lupus nephritis
F-M Wang et al.
LUPUS (2016)
Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study
Jeffrey A. Sparks et al.
ARTHRITIS CARE & RESEARCH (2016)
Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis
Jurgen Dieker et al.
PLOS ONE (2016)
C-reactive protein and inflammation: conformational changes affect function
Yi Wu et al.
BIOLOGICAL CHEMISTRY (2015)
Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up
Satu Sinikka Pesickova et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro
Yun Pang et al.
IMMUNOBIOLOGY (2014)
Pathogenic role of antibodies against monomeric C-reactive protein in tubulointerstitial nephritis and uveitis syndrome
K. Jakuszko et al.
INTERNAL MEDICINE JOURNAL (2014)
Paraneoplastic syndromes in rheumatology
Bernhard Manger et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Association of Serum C-Reactive Protein Levels With Lupus Disease Activity in the Absence of Measurable Interferon-α and a C-Reactive Protein Gene Variant
Helena Enocsson et al.
ARTHRITIS & RHEUMATOLOGY (2014)
C-Reactive Protein Inhibits Plasmacytoid Dendritic Cell Interferon Responses to Autoantibody Immune Complexes
Carolyn Mold et al.
ARTHRITIS AND RHEUMATISM (2013)
C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis
Christopher Sjowall et al.
AUTOIMMUNITY (2013)
The interferon signature in autoimmune diseases
Lars Ronnblom et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus
Helena Enocsson et al.
TRANSLATIONAL RESEARCH (2013)
2012 Provisional Classification Criteria for Polymyalgia Rheumatica A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative
Bhaskar Dasgupta et al.
ARTHRITIS AND RHEUMATISM (2012)
Amyloid Plaques Dissociate Pentameric to Monomeric C-Reactive Protein: A Novel Pathomechanism Driving Cortical Inflammation in Alzheimer's Disease?
Frederik Strang et al.
BRAIN PATHOLOGY (2012)
Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction
Jonathon Habersberger et al.
CARDIOVASCULAR RESEARCH (2012)
High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation
Christopher Sjowall et al.
HUMAN IMMUNOLOGY (2012)
The interferons and their receptors-distribution and regulation
Nicole A. de Weerd et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study
C. Bengtsson et al.
LUPUS (2012)
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
A. Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow
Blanca Molins et al.
CARDIOVASCULAR RESEARCH (2011)
Angiotensin II Induces the Expression of C-reactive Protein via MAPK-Dependent Signal Pathway in U937 Macrophages
Ming Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
A redox switch in C-reactive protein modulates activation of endothelial cells
Ming-Yu Wang et al.
FASEB JOURNAL (2011)
Monomeric C-reactive protein modulates classic complement activation on necrotic cells
Michael Mihlan et al.
FASEB JOURNAL (2011)
Complement Regulation at Necrotic Cell Lesions Is Impaired by the Age-Related Macular Degeneration-Associated Factor-H His402 Risk Variant
Nadine Lauer et al.
JOURNAL OF IMMUNOLOGY (2011)
Recognition and functional activation of the human IgA receptor (FcαRI) by C-reactive protein
Jinghua Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study
Lena Innala et al.
ARTHRITIS RESEARCH & THERAPY (2011)
CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation
Christina Janko et al.
FRONTIERS IN IMMUNOLOGY (2011)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Antibodies to Apolipoprotein A-I, High-Density Lipoprotein, and C-Reactive Protein Are Associated With Disease Activity in Patients With Systemic Lupus Erythematosus
Sean G. O'Neill et al.
ARTHRITIS AND RHEUMATISM (2010)
Modified C-Reactive Protein Is Expressed by Stroke Neovessels and Is a Potent Activator of Angiogenesis In Vitro
Mark Slevin et al.
BRAIN PATHOLOGY (2010)
Genetic Variants in the C-Reactive Protein Gene Are Associated with Microangiopathic Ischemic Stroke
Gregor Kuhlenbaeumer et al.
CEREBROVASCULAR DISEASES (2010)
IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells
C. GABAY et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4
Mario Hebecker et al.
MOLECULAR IMMUNOLOGY (2010)
Serum C-Reactive Protein and Risk of Cardiovascular Events in Middle-Aged and Older Chinese Population
Shan Jiang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Interferon-α Mediates Suppression of C-Reactive Protein Explanation for Muted C-Reactive Protein Response in Lupus Flares?
Helena Enocsson et al.
ARTHRITIS AND RHEUMATISM (2009)
C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: The JACC Study
Hiroyasu Iso et al.
ATHEROSCLEROSIS (2009)
C-reactive protein How conformational changes influence inflammatory properties
Steffen U. Eisenhardt et al.
CELL CYCLE (2009)
Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H
M. Mihlan et al.
CELL DEATH AND DIFFERENTIATION (2009)
Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques
Steffen U. Eisenhardt et al.
CIRCULATION RESEARCH (2009)
Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains
Shang-Rong Ji et al.
FASEB JOURNAL (2009)
Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells
Michael Mihlan et al.
MOLECULAR IMMUNOLOGY (2009)
C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis
Amy H. Kao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth
Blanca Molins et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
C-Reactive Protein and Systemic Lupus Erythematosus
Shilpa Gaitonde et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
J. Antonio Avina-Zubieta et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction The Reynolds Risk Score for Men
Paul M. Ridker et al.
CIRCULATION (2008)
Structural recognition and functional activation of FcγR by innate pentraxins
Jinghua Lu et al.
NATURE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus
Shin-Seok Lee et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk
Fadi G. Hage et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjogren's syndrome A antibodies
L. Mathsson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction
Christopher Sjowall et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins
Christopher Sjowall et al.
CLINICA CHIMICA ACTA (2007)
Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m)
Shang-Rong Ji et al.
FASEB JOURNAL (2007)
C-reactive protein: a nontraditional serum marker of cardiovascular risk
Sarah D. de Ferranti et al.
CARDIOVASCULAR PATHOLOGY (2007)
Complement deficiencies and systemic lupus erythematosus
Lennart Truedsson et al.
AUTOIMMUNITY (2007)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
Mortality in systemic lupus erythematosus
S. Bernatsky et al.
ARTHRITIS AND RHEUMATISM (2006)
Regulation of complement activation by C-reactive protein:: Targeting of the inhibitory activity of C4b-binding protein
Andreas P. Sjöberg et al.
JOURNAL OF IMMUNOLOGY (2006)
C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fcγ receptors
Carolyn Mold et al.
JOURNAL OF IMMUNOLOGY (2006)
Antibodies to C reactive protein
BJ Rosenau et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Effect of modified C-reactive protein on complement activation - A possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions
SR Ji et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
C-reactive protein: A family of proteins to regulate cardiovascular function
SB Schwedler et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Interactions of C-reactive protein with low-density lipoproteins: Implications for an active role of modified C-reactive protein in atherosclerosis
SR Ji et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils
T Khreiss et al.
CIRCULATION RESEARCH (2005)
Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis - A ten-year followup study of a primary care-based inception cohort
NJ Goodson et al.
ARTHRITIS AND RHEUMATISM (2005)
Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA).: XXX:: association between C-reactive protein (CRP) gene polymorphisms and vascular events
AJ Szalai et al.
RHEUMATOLOGY (2005)
Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level
AJ Szalai et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Cardiovascular Death in Rheumatoid Arthritis A Population-Based Study
Hilal Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells
T Khreiss et al.
CIRCULATION (2004)
Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction
LM Fischer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcγRIIa
DE Manolov et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
C Sjowall et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus
AI Russell et al.
HUMAN MOLECULAR GENETICS (2004)
C-reactive protein
S Black et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood
T Khreiss et al.
CIRCULATION (2004)
The role of complement in the development of systemic lupus erythematosus
AP Manderson et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells
P Calabró et al.
CIRCULATION (2003)
FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG
U Båve et al.
JOURNAL OF IMMUNOLOGY (2003)
C-reactive protein: a critical update
MB Pepys et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The kidney as a second site of human C-reactive protein formation in vivo
WJ Jabs et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Tubular staining of modified C-reactive protein in diabetic chronic kidney disease
SB Schwedler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren's syndrome, rheumatoid arthritis or inflammatory bowel disease
C Sjöwall et al.
JOURNAL OF AUTOIMMUNITY (2002)
Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils
T Khreiss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion
C Zouki et al.
JOURNAL OF IMMUNOLOGY (2001)
Expression of C-reactive protein in the human respiratory tract
JM Gould et al.
INFECTION AND IMMUNITY (2001)
Transactivation of c-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer finding protein β (C/EBPβ) and Rel p50
A Agrawal et al.
JOURNAL OF IMMUNOLOGY (2001)
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.
B Lindahl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)